|
| Total number of patients (N = 2399) | No surgery (N = 1511) | Received surgery (N = 888) |
| Age at Index, mean (SD)* | 60.2 (14.4) | 60.9 (14.3) | 59.0 (14.5) |
| 18 - 30, % | 2.4 | 2.2 | 2.7 |
| 30 - 50, % | 18.9 | 17.8 | 21.0 |
| 50 - 65, % | 44.2 | 43.2 | 45.8 |
| ≥65, %* | 34.5 | 36.8 | 30.5 |
| Female, % | 37.3 | 36.3 | 39.1 |
| Health Insurance Plan |
|
|
|
| Comprehensive | 18.3 | 18.5 | 17.9 |
| HMO | 13.4 | 14.2 | 12.2 |
| POS | 6.1 | 6.4 | 5.5 |
| PPO | 54.2 | 53.5 | 55.5 |
| Other plans | 8.0 | 7.4 | 8.9 |
| Metastatic site at Index, % |
|
|
|
| Lung | 14.3 | 15.2 | 12.8 |
| Brain* | 12.4 | 14.8 | 8.2 |
| Distant skin* | 18.3 | 12.7 | 27.7 |
| Bone* | 7.2 | 8.5 | 5.0 |
| Liver* | 6.7 | 8.0 | 4.5 |
| Multiple sites* | 9.5 | 11.5 | 6.1 |
| Length of follow-up, mean days (SD)* | 376.5 (426.7) | 275.9 (333.4) | 547.8 (506.3) |
| Length of follow-up, median days* | 224 | 161 | 383.5 |